Contact dermatitis with clostridiopeptidase A contained in Noruxol ointment.

Contact Dermatitis

Unit of Dermatology, Department of Internal Medicine, Immunology and Infectious Diseases, University of Bari, Policlinico, Piazza Giulio Cesare, 11, I-70124 Bari, Italy.

Published: June 2007

AI Article Synopsis

  • Clostridiopeptidase A, or collagenase 1, is an enzyme that helps break down collagen and is used in treatments for skin wounds and ulcers.
  • Patients using Noruxol ointment, which contains this enzyme, developed periulcerative eczema, prompting further allergy testing.
  • Patch testing revealed that most patients had questionable reactions to the ointment, but all reacted positively to clostridiopeptidase A, indicating its potential to cause sensitization in certain individuals.

Article Abstract

Clostridiopeptidase A, also called collagenase 1, is a proteolytic enzyme capable of digesting collagen. Preparations containing clostridiopeptidase A are used topically for the debridement of dermal ulcers, burns and other necrotic lesions to facilitate the formation of granulation tissue and subsequent epithelization. We observed 4 patients with a periulcerative eczema after repeated applications of Noruxol ointment (Smith & Nephew Ltd, L Hull, UK). Patch testing with Noruxol ointment as is and its excipients (soft paraffin and white petrolatum), as well as scaled dilutions of the main ingredient of this topical preparation, clostridiopeptidase A (Firma, Florence, Italy), showed doubtful reactions to Noruxol ointment in 3 patients and a positive reactions only in 1 patient. All patients showed positive reactions to clostridiopeptidase A 1% in pet. This study shows the sensitizing capacity of clostridiopeptidase A that should be tested in all patients with suspect sensitization to Noruxol ointment.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0536.2006.01056.xDOI Listing

Publication Analysis

Top Keywords

noruxol ointment
20
patients positive
8
positive reactions
8
clostridiopeptidase
6
noruxol
5
ointment
5
contact dermatitis
4
dermatitis clostridiopeptidase
4
clostridiopeptidase contained
4
contained noruxol
4

Similar Publications

Contact dermatitis with clostridiopeptidase A contained in Noruxol ointment.

Contact Dermatitis

June 2007

Unit of Dermatology, Department of Internal Medicine, Immunology and Infectious Diseases, University of Bari, Policlinico, Piazza Giulio Cesare, 11, I-70124 Bari, Italy.

Article Synopsis
  • Clostridiopeptidase A, or collagenase 1, is an enzyme that helps break down collagen and is used in treatments for skin wounds and ulcers.
  • Patients using Noruxol ointment, which contains this enzyme, developed periulcerative eczema, prompting further allergy testing.
  • Patch testing revealed that most patients had questionable reactions to the ointment, but all reacted positively to clostridiopeptidase A, indicating its potential to cause sensitization in certain individuals.
View Article and Find Full Text PDF

Objective: A large retrospective analysis was performed to assess the outcomes of burns and chronic ulcers treated with collagenase in an outpatient setting. No cost comparison was performed.

Method: Of 979 patients entered into the analysis, 647 had burns affecting < or = 15% body surface area (BSA) and 332 had chronic ulcers of various aetiologies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!